Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581474A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
10/05/2005EP1581472A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
10/05/2005EP1581309A2 Kinase modulators
10/05/2005EP1581308A2 Treatment of chronic heart failure
10/05/2005EP1581258A1 Pharmaceutical formulation and a method of making same
10/05/2005EP1581252A1 Wound and skin care products
10/05/2005EP1581241A2 Stimulation of vascularization with vegf-b
10/05/2005EP1581240A1 Cholesterol-reducing agent containing an n-3 fatty acid
10/05/2005EP1581236A2 Sustained release of antiinfectives
10/05/2005EP1581235A1 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia
10/05/2005EP1581234A2 Methods for treating migraine
10/05/2005EP1581233A2 Compositions and methods for pain reduction
10/05/2005EP1581232A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
10/05/2005EP1581231A1 Anti-viral compounds
10/05/2005EP1581230A2 Method and compositions for treating anxiety
10/05/2005EP1581228A1 Treatment of von hippel lindau disease
10/05/2005EP1581227A1 A method for treating renal failure
10/05/2005EP1581226A1 Inclusion complex of anti-tubercular rifampicin with beta-cyclodextrin or 2-hydroxypropyl beta-cyclodextrin and a process for producing the same
10/05/2005EP1581225A1 Combination therapy for the treatment of pain
10/05/2005EP1581224A1 Tiotropium-containing medicament combinations used for inhaling
10/05/2005EP1581223A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
10/05/2005EP1581222A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
10/05/2005EP1581221A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
10/05/2005EP1581219A1 Treatment of psychostimulant addiction
10/05/2005EP1581217A1 Carbonylamino-benzimidazole derivatives as androgen receptor modulators
10/05/2005EP1581216A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells
10/05/2005EP1581215A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
10/05/2005EP1581213A1 3,5-disubstituted- 1,2,4 -oxadiazoles and analogs as ac tivators of caspases and inducers of apoptosis and the use thereof
10/05/2005EP1581212A2 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
10/05/2005EP1581211A1 Contact lens and eye drop rewetter compositions and their uses
10/05/2005EP1581210A1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
10/05/2005EP1581209A2 Novel benzopyran analogs and their use for the treatment of glaucoma
10/05/2005EP1581207A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/05/2005EP1581206A1 Treatment of inflammatory disorders with 2,3-benzodiazepines
10/05/2005EP1581205A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
10/05/2005EP1581204A1 Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (paba)
10/05/2005EP1581203A1 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/05/2005EP1581202A2 Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
10/05/2005EP1581200A2 Compositions and methods for nutrition supplementation
10/05/2005EP1581199A1 Orally administrable composition for improving skin quality
10/05/2005EP1581198A1 Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
10/05/2005EP1581197A1 Coating composition for taste masking coating and methods for their application and use
10/05/2005EP1581196A1 Acid labile drug compositions
10/05/2005EP1581194A2 Multilayered tablet containing pravastatin and aspirin and method
10/05/2005EP1581192A1 Improved formulations containing substituted imidazole derivatives
10/05/2005EP1581191A1 Pharmaceutical compositions comprising amoxicillin and clavulanic acid
10/05/2005EP1581187A2 Compositions and methods related to lipid:emodin formulations
10/05/2005EP1581186A2 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
10/05/2005EP1581184A1 Veterinary compositions for treating mastitis
10/05/2005EP1581182A2 Aerosolizable pharmaceutical formulation for fungal infection therapy
10/05/2005EP1581178A1 Cosmetic composition based on cirsimarin
10/05/2005EP1581172A2 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
10/05/2005EP1581167A2 Compositions and methods for the treatment of parkinson's disease and tardive dyskinesias
10/05/2005EP1581165A2 Novel factor viia inhibiting compounds
10/05/2005EP1581163A2 Use of istradefylline (kw-6002) for the treatment of behavioral disorders
10/05/2005EP1581149A1 Method for treating patients for radiation exposure
10/05/2005EP1581095A2 Therapeutic methods for reducing fat deposition and treating associated conditions
10/05/2005EP1581094A2 Kits and methods for assessing skin health
10/05/2005EP1516866A9 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
10/05/2005EP1511475B1 A herbal molecule as potential anti-leukemic drug
10/05/2005EP1419154B1 Rapamycin 29-enols
10/05/2005EP1385536B1 Preparations containing a combination of vitamin e and afamin
10/05/2005EP1370271B1 A process for the manufacture of a herbal composition comprising a matrine
10/05/2005EP1339393B1 A method for restoring the fat-pad
10/05/2005EP1325008B1 Piperazine derivatives
10/05/2005EP1294370B1 Triterpenoid derivatives
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1269973B1 Hair growth stimulant compositions
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1257280B1 Pharmaceutical combination of micronised drospirenone and an estrogen for hormone replacement therapy
10/05/2005EP1252891B1 Use of DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVES FOR the prevention and treatment of LIVER DISEASES
10/05/2005EP1251874B1 Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant
10/05/2005EP1248654B1 Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
10/05/2005EP1242086B1 Cd45 inhibitors
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1230217B1 Positive modulators of nicotinic receptor agonists
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1197210B1 Agents inhibiting chronic rejection reactions after organ transplantation
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1158978B1 Medicament against dysmenorrhoea and premenstrual syndrome comprising lidocaine
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005EP1133279B1 Method of producing vitamin powders
10/05/2005EP1094804B1 The treatment of renal colic with gaba analogs
10/05/2005EP1084693B1 Alpha-hydroxy fatty acid derivatives and composition for external use containing the same
10/05/2005EP1083887B1 Pharmaceutical compositions for the treatment of ulcers
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005EP1001783B1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
10/05/2005EP0990002B1 Dextran derivatives, preparation method and applications as medicine with specific biological action
10/05/2005EP0914157B1 Anti-tnf antibodies / tnf receptor and methotrexate in the treatment of autoimmune disease
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005EP0621779B1 Indomethacin lysinate for therapeutic use in ophthalmology
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678626A Estrieno[3, 2-b]/[3, 4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/05/2005CN1678621A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
10/05/2005CN1678620A Macrolide compounds endowed with antiinflammatory activity
10/05/2005CN1678619A Compounds that interact with kinases
10/05/2005CN1678616A Cephalosporins
10/05/2005CN1678615A Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
10/05/2005CN1678614A Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
1 ... 4518 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 4532 4533 4534 4535 4536 4537 4538 ... 7860